---
title: Site-specific activation of the proton pump inhibitor rabeprazole by tetrathiolate
  zinc centres
date: '2025-02-20'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39979415/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250221170849&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Proton pump inhibitors have become top-selling drugs worldwide. Serendipitously
  discovered as prodrugs that are activated by protonation in acidic environments,
  proton pump inhibitors inhibit stomach acid secretion by covalently modifying the
  gastric proton pump. Despite their widespread use, alternative activation mechanisms
  and potential target proteins in non-acidic environments remain poorly understood.
  Employing a chemoproteomic approach, we found that the proton pump inhibitor ...
disable_comments: true
---
Proton pump inhibitors have become top-selling drugs worldwide. Serendipitously discovered as prodrugs that are activated by protonation in acidic environments, proton pump inhibitors inhibit stomach acid secretion by covalently modifying the gastric proton pump. Despite their widespread use, alternative activation mechanisms and potential target proteins in non-acidic environments remain poorly understood. Employing a chemoproteomic approach, we found that the proton pump inhibitor ...